APO Research
Talk to an analyst

APO RESEARCH · REPORT

Zika Vaccines

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Zika Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

21 December 2025181 pages

Choose your research edition.

Industry ResearchZika Vaccines Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Zika Vaccines Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Zika Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Zika Vaccines Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Zika Vaccines Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Zika Vaccines market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Zika Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Zika Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Zika Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Zika Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Zika Vaccines include Sanofi, GlaxoSmithKline, NewLink Genetics, Inovio Pharmaceuticals, Immunovaccine, Cerus Corporation and Bharat Biotech, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Zika Vaccines market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Zika Vaccines and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Zika Vaccines sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Zika Vaccines market size, projected growth trends, production technologies, key applications, and end-use industries.

Zika Vaccines Segment by Company

Sanofi

GlaxoSmithKline

NewLink Genetics

Inovio Pharmaceuticals

Immunovaccine

Cerus Corporation

Bharat Biotech

Zika Vaccines Segment by Type

Therapeutic Vaccines

Preventive Vaccines

Zika Vaccines Segment by Application

Clinics

Hospitals

Ambulatory Surgery Centers

Others

Zika Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Zika Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Zika Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Zika Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Zika Vaccines market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Zika Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Zika Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Zika Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Zika Vaccines Industry Trends Table 2. Zika Vaccines Industry Drivers Table 3. Zika Vaccines Industry Opportunities and Challenges Table 4. Zika Vaccines Industry Restraints Table 5. Global Zika Vaccines Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Zika Vaccines Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Zika Vaccines Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Zika Vaccines Sales Market Share by Manufacturers Table 9. Global Zika Vaccines Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Zika Vaccines Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Zika Vaccines Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Zika Vaccines Manufacturers, Product Type & Application Table 13. Global Zika Vaccines Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Zika Vaccines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Therapeutic Vaccines Table 17. Major Manufacturers of Preventive Vaccines Table 18. Global Zika Vaccines Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global Zika Vaccines Sales by Type (2021-2026) & (k units) Table 20. Global Zika Vaccines Sales by Type (2027-2032) & (k units) Table 21. Global Zika Vaccines Sales Market Share by Type (2021-2026) Table 22. Global Zika Vaccines Sales Market Share by Type (2027-2032) Table 23. Global Zika Vaccines Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Zika Vaccines Revenue by Type (2021-2026) & (k units) Table 25. Global Zika Vaccines Revenue by Type (2027-2032) & (k units) Table 26. Global Zika Vaccines Revenue Market Share by Type (2021-2026) Table 27. Global Zika Vaccines Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Clinics Table 29. Major Manufacturers of Hospitals Table 30. Major Manufacturers of Ambulatory Surgery Centers Table 31. Major Manufacturers of Others Table 32. Global Zika Vaccines Sales by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global Zika Vaccines Sales by Application (2021-2026) & (k units) Table 34. Global Zika Vaccines Sales by Application (2027-2032) & (k units) Table 35. Global Zika Vaccines Sales Market Share by Application (2021-2026) Table 36. Global Zika Vaccines Sales Market Share by Application (2027-2032) Table 37. Global Zika Vaccines Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 38. Global Zika Vaccines Revenue by Application (2021-2026) & (k units) Table 39. Global Zika Vaccines Revenue by Application (2027-2032) & (k units) Table 40. Global Zika Vaccines Revenue Market Share by Application (2021-2026) Table 41. Global Zika Vaccines Revenue Market Share by Application (2027-2032) Table 42. Global Zika Vaccines Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global Zika Vaccines Sales by Region (2021-2026) & (k units) Table 44. Global Zika Vaccines Sales Market Share by Region (2021-2026) Table 45. Global Zika Vaccines Sales Forecasted by Region (2027-2032) & (k units) Table 46. Global Zika Vaccines Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Zika Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 48. North America Zika Vaccines Sales by Country (2021-2026) & (k units) Table 49. North America Zika Vaccines Sales by Country (2027-2032) & (k units) Table 50. Europe Zika Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 51. Europe Zika Vaccines Sales by Country (2021-2026) & (k units) Table 52. Europe Zika Vaccines Sales by Country (2027-2032) & (k units) Table 53. Asia Pacific Zika Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 54. Asia Pacific Zika Vaccines Sales by Country (2021-2026) & (k units) Table 55. Asia Pacific Zika Vaccines Sales by Country (2027-2032) & (k units) Table 56. South America, Middle East and Africa Zika Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 57. South America, Middle East and Africa Zika Vaccines Sales by Country (2021-2026) & (k units) Table 58. South America, Middle East and Africa Zika Vaccines Sales by Country (2027-2032) & (k units) Table 59. Global Zika Vaccines Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Zika Vaccines Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Zika Vaccines Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Zika Vaccines Revenue Market Share by Region (2021-2026) Table 63. Global Zika Vaccines Revenue Market Share by Region (2027-2032) Table 64. Sanofi Company Information Table 65. Sanofi Business Overview Table 66. Sanofi Zika Vaccines Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Sanofi Zika Vaccines Product Portfolio Table 68. Sanofi Recent Development Table 69. GlaxoSmithKline Company Information Table 70. GlaxoSmithKline Business Overview Table 71. GlaxoSmithKline Zika Vaccines Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. GlaxoSmithKline Zika Vaccines Product Portfolio Table 73. GlaxoSmithKline Recent Development Table 74. NewLink Genetics Company Information Table 75. NewLink Genetics Business Overview Table 76. NewLink Genetics Zika Vaccines Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. NewLink Genetics Zika Vaccines Product Portfolio Table 78. NewLink Genetics Recent Development Table 79. Inovio Pharmaceuticals Company Information Table 80. Inovio Pharmaceuticals Business Overview Table 81. Inovio Pharmaceuticals Zika Vaccines Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Inovio Pharmaceuticals Zika Vaccines Product Portfolio Table 83. Inovio Pharmaceuticals Recent Development Table 84. Immunovaccine Company Information Table 85. Immunovaccine Business Overview Table 86. Immunovaccine Zika Vaccines Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Immunovaccine Zika Vaccines Product Portfolio Table 88. Immunovaccine Recent Development Table 89. Cerus Corporation Company Information Table 90. Cerus Corporation Business Overview Table 91. Cerus Corporation Zika Vaccines Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Cerus Corporation Zika Vaccines Product Portfolio Table 93. Cerus Corporation Recent Development Table 94. Bharat Biotech Company Information Table 95. Bharat Biotech Business Overview Table 96. Bharat Biotech Zika Vaccines Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Bharat Biotech Zika Vaccines Product Portfolio Table 98. Bharat Biotech Recent Development Table 99. Key Raw Materials Table 100. Raw Materials Key Suppliers Table 101. Zika Vaccines Distributors List Table 102. Zika Vaccines Customers List Table 103. Research Programs/Design for This Report Table 104. Authors List of This Report Table 105. Secondary Sources Table 106. Primary Sources List of Figures Figure 1. Zika Vaccines Product Image Figure 2. Global Zika Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Zika Vaccines Market Size (2021-2032) & (US$ Million) Figure 4. Global Zika Vaccines Sales (2021-2032) & (k units) Figure 5. Global Zika Vaccines Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Zika Vaccines Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Therapeutic Vaccines Image Figure 9. Preventive Vaccines Image Figure 10. Global Zika Vaccines Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global Zika Vaccines Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Zika Vaccines Sales Market Share by Type (2021-2032) Figure 13. Global Zika Vaccines Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Zika Vaccines Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Zika Vaccines Revenue Market Share by Type (2021-2032) Figure 16. Clinics Image Figure 17. Hospitals Image Figure 18. Ambulatory Surgery Centers Image Figure 19. Others Image Figure 20. Global Zika Vaccines Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global Zika Vaccines Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Zika Vaccines Sales Market Share by Application (2021-2032) Figure 23. Global Zika Vaccines Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 24. Global Zika Vaccines Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Zika Vaccines Revenue Market Share by Application (2021-2032) Figure 26. North America Zika Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 27. North America Zika Vaccines Sales Market Share by Country (2021-2032) Figure 28. U.S. Zika Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 29. Canada Zika Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 30. Mexico Zika Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe Zika Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 32. Europe Zika Vaccines Sales Market Share by Country (2021-2032) Figure 33. Germany Zika Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 34. France Zika Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 35. U.K. Zika Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 36. Italy Zika Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 37. Netherlands Zika Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific Zika Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 39. Asia Pacific Zika Vaccines Sales Market Share by Country (2021-2032) Figure 40. China Zika Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 41. Japan Zika Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 42. South Korea Zika Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 43. Southeast Asia Zika Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 44. India Zika Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 45. Australia Zika Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa Zika Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 47. South America, Middle East and Africa Zika Vaccines Sales Market Share by Country (2021-2032) Figure 48. Brazil Zika Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 49. South Africa Zika Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 50. Saudi Arabia Zika Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 51. Turkey Zika Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 52. Argentina Zika Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 53. UAE Zika Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 54. Egypt Zika Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 55. Chile Zika Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 56. Global Zika Vaccines Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Zika Vaccines Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Zika Vaccines Revenue (2021-2032) & (US$ Million) Figure 59. North America Zika Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Zika Vaccines Revenue (2021-2032) & (US$ Million) Figure 61. Europe Zika Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Zika Vaccines Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Zika Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Zika Vaccines Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Zika Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Zika Vaccines Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Zika Vaccines Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Therapeutic Vaccines
  • Preventive Vaccines
Applications
  • Clinics
  • Hospitals
  • Ambulatory Surgery Centers
  • Others
Companies covered
  • Sanofi
  • GlaxoSmithKline
  • NewLink Genetics
  • Inovio Pharmaceuticals
  • Immunovaccine
  • Cerus Corporation
  • Bharat Biotech

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Zika Vaccines Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Zika Vaccines Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Zika Vaccines Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Zika Vaccines Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Zika Vaccines Market Dynamics
  1. 2.1 Zika Vaccines Industry Trends
  2. 2.2 Zika Vaccines Industry Drivers
  3. 2.3 Zika Vaccines Industry Opportunities and Challenges
  4. 2.4 Zika Vaccines Industry Restraints
3 Zika Vaccines Market by Manufacturers
  1. 3.1 Global Zika Vaccines Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Zika Vaccines Sales by Manufacturers (2021-2026)
  3. 3.3 Global Zika Vaccines Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Zika Vaccines Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Zika Vaccines Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Zika Vaccines Manufacturers, Product Type & Application
  7. 3.7 Global Zika Vaccines Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Zika Vaccines Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Zika Vaccines Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Zika Vaccines Tier 1, Tier 2, and Tier 3
4 Zika Vaccines Market by Type
  1. 4.1 Zika Vaccines Type Introduction
  2. 4.1.1 Therapeutic Vaccines
  3. 4.1.2 Preventive Vaccines
  4. 4.2 Global Zika Vaccines Sales by Type
  5. 4.2.1 Global Zika Vaccines Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Zika Vaccines Sales by Type (2021-2032)
  7. 4.2.3 Global Zika Vaccines Sales Market Share by Type (2021-2032)
  8. 4.3 Global Zika Vaccines Revenue by Type
  9. 4.3.1 Global Zika Vaccines Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Zika Vaccines Revenue by Type (2021-2032)
  11. 4.3.3 Global Zika Vaccines Revenue Market Share by Type (2021-2032)
5 Zika Vaccines Market by Application
  1. 5.1 Zika Vaccines Application Introduction
  2. 5.1.1 Clinics
  3. 5.1.2 Hospitals
  4. 5.1.3 Ambulatory Surgery Centers
  5. 5.1.4 Others
  6. 5.2 Global Zika Vaccines Sales by Application
  7. 5.2.1 Global Zika Vaccines Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Zika Vaccines Sales by Application (2021-2032)
  9. 5.2.3 Global Zika Vaccines Sales Market Share by Application (2021-2032)
  10. 5.3 Global Zika Vaccines Revenue by Application
  11. 5.3.1 Global Zika Vaccines Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Zika Vaccines Revenue by Application (2021-2032)
  13. 5.3.3 Global Zika Vaccines Revenue Market Share by Application (2021-2032)
6 Global Zika Vaccines Sales by Region
  1. 6.1 Global Zika Vaccines Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Zika Vaccines Sales by Region (2021-2032)
  3. 6.2.1 Global Zika Vaccines Sales by Region (2021-2026)
  4. 6.2.2 Global Zika Vaccines Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Zika Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Zika Vaccines Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Zika Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Zika Vaccines Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Zika Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Zika Vaccines Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Zika Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Zika Vaccines Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Zika Vaccines Revenue by Region
  1. 7.1 Global Zika Vaccines Revenue by Region
  2. 7.1.1 Global Zika Vaccines Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Zika Vaccines Revenue by Region (2021-2026)
  4. 7.1.3 Global Zika Vaccines Revenue by Region (2027-2032)
  5. 7.1.4 Global Zika Vaccines Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Zika Vaccines Revenue (2021-2032)
  8. 7.2.2 North America Zika Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Zika Vaccines Revenue (2021-2032)
  11. 7.3.2 Europe Zika Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Zika Vaccines Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Zika Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Zika Vaccines Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Zika Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Sanofi
  2. 8.1.1 Sanofi Company Information
  3. 8.1.2 Sanofi Business Overview
  4. 8.1.3 Sanofi Zika Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Sanofi Zika Vaccines Product Portfolio
  6. 8.1.5 Sanofi Recent Developments
  7. 8.2 GlaxoSmithKline
  8. 8.2.1 GlaxoSmithKline Company Information
  9. 8.2.2 GlaxoSmithKline Business Overview
  10. 8.2.3 GlaxoSmithKline Zika Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 GlaxoSmithKline Zika Vaccines Product Portfolio
  12. 8.2.5 GlaxoSmithKline Recent Developments
  13. 8.3 NewLink Genetics
  14. 8.3.1 NewLink Genetics Company Information
  15. 8.3.2 NewLink Genetics Business Overview
  16. 8.3.3 NewLink Genetics Zika Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 NewLink Genetics Zika Vaccines Product Portfolio
  18. 8.3.5 NewLink Genetics Recent Developments
  19. 8.4 Inovio Pharmaceuticals
  20. 8.4.1 Inovio Pharmaceuticals Company Information
  21. 8.4.2 Inovio Pharmaceuticals Business Overview
  22. 8.4.3 Inovio Pharmaceuticals Zika Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Inovio Pharmaceuticals Zika Vaccines Product Portfolio
  24. 8.4.5 Inovio Pharmaceuticals Recent Developments
  25. 8.5 Immunovaccine
  26. 8.5.1 Immunovaccine Company Information
  27. 8.5.2 Immunovaccine Business Overview
  28. 8.5.3 Immunovaccine Zika Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Immunovaccine Zika Vaccines Product Portfolio
  30. 8.5.5 Immunovaccine Recent Developments
  31. 8.6 Cerus Corporation
  32. 8.6.1 Cerus Corporation Company Information
  33. 8.6.2 Cerus Corporation Business Overview
  34. 8.6.3 Cerus Corporation Zika Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Cerus Corporation Zika Vaccines Product Portfolio
  36. 8.6.5 Cerus Corporation Recent Developments
  37. 8.7 Bharat Biotech
  38. 8.7.1 Bharat Biotech Company Information
  39. 8.7.2 Bharat Biotech Business Overview
  40. 8.7.3 Bharat Biotech Zika Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Bharat Biotech Zika Vaccines Product Portfolio
  42. 8.7.5 Bharat Biotech Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Zika Vaccines Value Chain Analysis
  2. 9.1.1 Zika Vaccines Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Zika Vaccines Production Mode & Process
  6. 9.2 Zika Vaccines Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Zika Vaccines Distributors
  9. 9.2.3 Zika Vaccines Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst